Chikungunya Virus as Cause of Febrile Illness Outbreak, Chiapas, Mexico, 2014
Tiffany F. Kautz
1, Esteban E. Díaz-González
1, Jesse H. Erasmus, Iliana R. Malo-García, Rose M. Langsjoen, Edward I. Patterson, Dawn I. Auguste, Naomi L. Forrester, Rosa Maria Sanchez-Casas, Mauricio Hernández-Ávila, Celia M. Alpuche-Aranda, Nikos Vasilakis

, and Ildefonso Fernández-Salas
Author affiliations: University of Texas Medical Branch, Galveston, Texas, USA (T.F. Kautz, J.H. Erasmus, R.M. Langsjoen, E.I. Patterson, D.I. Auguste, N.L. Forrester, S.C. Weaver); Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Mexico (E.E. Diaz-Gonzalez); Centro Regional de Investigación en Salud Pública, Tapachula, Mexico (I.R. Malo-García, I. Fernandez-Salas); Universidad Autónoma de Nuevo León, Escobedo, Mexico (R.M. Sanchez-Casas); Instituto Nacional de Salud Pública, Cuernavaca, México (M. Hernández-Ávila, C.M. Alpuche-Aranda)
Main Article
Table
Proportions of CHIKV viremia and IgM in 119 serum samples collected at 3 collection sites in Chiapas, Mexico, October–December 2014*
Collection site |
No. serum samples |
% qRT-PCR positive serum samples (no.) |
Mean serum virus titer, log10 PFU/mL (±SD) |
% IgM-positive serum samples† (no.) |
La Libertad |
43 |
20 (9) |
3.26 (0.57) |
51.2 (22) |
Ciudad Hidalgo |
63 |
23.8 (15) |
3.36 (0.56) |
68.2 (43) |
Tapachula |
13 |
30.8 (4) |
3.66 |
7.7 (1) |
Main Article
Page created: October 19, 2015
Page updated: October 19, 2015
Page reviewed: October 19, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.